Respiratory Syncytial Virus (RSV) is a leading cause of respiratory infections in infants and older adults. In Spain, surveillance is supported by the SiVIRA system and the RELECOV genomic sequencing network.
Mas, Vicente +9 more
core +1 more source
Nirsevimab and Hospitalization for Lower Respiratory Tract Infection During the Second Season
OBJECTIVES To assess the effect of nirsevimab in preventing hospitalizations for lower respiratory tract infection (LRTI) during the second respiratory season of life among infants who were administered nirsevimab
Jesús Miguel Ríos-Hurtado +12 more
core +1 more source
Guideline for Weighing of Infants for Nirsevimab Administration.
Purpose To provide a standardised approach to determine the correct Nirsevimab dose for infants attending a catch-up clinic including mobile vaccination clinics: ensuring accurate dosing while avoiding unnecessary ...
Health Protection Surveillance Centre (HPSC)
core
Uptake and predictors of newborn respiratory syncytial virus (RSV) immunisation with nirsevimab in Ireland's national pilot programme: a cross-sectional study. [PDF]
BMJ OpenMasukume G +10 more
europepmc +1 more source
Contexte : le virus respiratoire syncytial (VRS) est la cause la plus fréquente de bronchiolite chez les nourrissons pouvant causer des atteintes graves allant jusqu’au décès.
Couteau, Lorène
core
RSV prophylactics for pediatric populations: A product review and meta-analysis of real-world effectiveness. [PDF]
Hum Vaccin ImmunotherOliva IO, Oliveira CR.
europepmc +1 more source
Administration Timing of Respiratory Syncytial Virus Preventatives Among Commercially Insured Populations in the United States: 2024-2025 RSV Season. [PDF]
Vaccines (Basel)Law AW +6 more
europepmc +1 more source
Impact of a national nirsevimab programme on critical care transport of babies with bronchiolitis: a retrospective observational study. [PDF]
Arch Dis ChildMoore T +6 more
europepmc +1 more source
Efectividad del nirsevimab en la prevención de infección por virus sincitial respiratorio en lactantes: revisión sistemática [PDF]
Introducción: El virus respiratorio sincitial (VSR) constituye una de las principales causas de infecciones respiratorias bajas en lactantes, asociado a elevada morbimortalidad y altas tasas de hospitalización, especialmente en menores de seis meses y ...
Arévalo Espinoza, José Luis
core
Protecting infants from RSV: cost-effectiveness of nirsevimab in a real-world study from Chile. [PDF]
Lancet Reg Health AmPriante E, Baraldi E.
europepmc +1 more source